Literature DB >> 2341170

Effect of Staphylococcus aureus delta-toxin on human granulocyte functions and platelet-activating-factor metabolism.

S Kasimir1, W Schönfeld, J E Alouf, W König.   

Abstract

The production of delta-toxin is supposed to be responsible for various pathophysiological effects during infection with Staphylococcus aureus. We compared the effects of delta-toxin with the structurally related bee venom toxin melittin on granulocyte functions and inflammatory mediator release. Delta-toxin and melittin induced a rapid Ca2+ influx, as was shown by fluorescence detection. Furthermore, oxygen radical production, as determined by luminol-enhanced chemiluminescence, was triggered by delta-toxin (0.15 to 15 micrograms/ml), whereas melittin showed only marginal effects. Release of lysozyme and beta-glucuronidase was observed only at high concentrations of 15 micrograms of melittin and delta-toxin per ml. Preincubation (15 min) of neutrophils with both toxins resulted in the formation of 3H-platelet-activating factor (3H-PAF) from 3H-lyso-PAF. After 5 min of incubation, the exogenously added lyso-PAF was converted to PAF (delta-toxin, 80 +/- 2%; melittin, 27 +/- 12% of total radioactivity; n = 3, mean +/- standard error of the mean) and 1-O-alkyl-2-acyl-glycerophosphorylcholine (alkyl-acyl-GPC) (corresponding values, 20 +/- 3% and 51 +/- 14% of total radioactivity). The newly generated PAF was rapidly metabolized to lyso-PAF and alkyl-acyl-GPC during the subsequent incubation period of 60 min. In the absence of any toxin, no formation of PAF from lyso-PAF was observed. Further studies indicated that the metabolism of PAF into lyso-PAF and alkyl-acyl-GPC was inhibited in the presence of delta-toxin. Melittin had no significant effects on PAF metabolism. Neither delta-toxin nor melittin modulated the uptake of PAF and lyso-PAF significantly. Our data provide evidence that delta-toxin has an effect on the activity of neutrophil granulocytes with regard to its proinflammatory capacity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2341170      PMCID: PMC258699          DOI: 10.1128/iai.58.6.1653-1659.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

Review 1.  Biology and biochemistry of platelet-activating factor.

Authors:  J T O'Flaherty; R L Wykle
Journal:  Clin Rev Allergy       Date:  1983-09

Review 2.  Toxins of Staphylococcus aureus.

Authors:  J H Freer; J P Arbuthnott
Journal:  Pharmacol Ther       Date:  1982       Impact factor: 12.310

3.  A new generation of Ca2+ indicators with greatly improved fluorescence properties.

Authors:  G Grynkiewicz; M Poenie; R Y Tsien
Journal:  J Biol Chem       Date:  1985-03-25       Impact factor: 5.157

4.  Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187.

Authors:  M Oda; K Satouchi; K Yasunaga; K Saito
Journal:  J Immunol       Date:  1985-02       Impact factor: 5.422

5.  Staphylococcal delta toxin-induced generation of chemiluminescence by human polymorphonuclear leukocytes.

Authors:  T Tomita; K Momoi; S Kanegasaki
Journal:  Toxicon       Date:  1984       Impact factor: 3.033

6.  The amino acid sequence of the delta haemolysin of Staphylococcus aureus.

Authors:  J E Fitton; A Dell; W V Shaw
Journal:  FEBS Lett       Date:  1980-06-30       Impact factor: 4.124

7.  Studies on molecular regulation of phagocytosis in neutrophils. Con A-mediated ingestion and associated respiratory burst independent of phosphoinositide turnover, rise in [Ca2+]i, and arachidonic acid release.

Authors:  F Rossi; V Della Bianca; M Grzeskowiak; F Bazzoni
Journal:  J Immunol       Date:  1989-03-01       Impact factor: 5.422

8.  1-O-alkyl-2-arachidonoyl-sn-glycero-3-phosphocholine. A common source of platelet-activating factor and arachidonate in human polymorphonuclear leukocytes.

Authors:  F H Chilton; J M Ellis; S C Olson; R L Wykle
Journal:  J Biol Chem       Date:  1984-10-10       Impact factor: 5.157

9.  Interaction of Staphylococcus aureus delta-lysin with phospholipid monolayers.

Authors:  M Bhakoo; T H Birkbeck; J H Freer
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

10.  Biosynthesis of Paf-acether (platelet-activating factor). VII. Precursors of Paf-acether and acetyl-transferase activity in human leukocytes.

Authors:  E Jouvin-Marche; E Ninio; G Beaurain; M Tence; P Niaudet; J Benveniste
Journal:  J Immunol       Date:  1984-08       Impact factor: 5.422

View more
  6 in total

1.  Staphylococcal culture supernates stimulate human phagocytes.

Authors:  K E Veldkamp; K P Van Kessel; J Verhoef; J A Van Strijp
Journal:  Inflammation       Date:  1997-10       Impact factor: 4.092

2.  Lipopolysaccharide induction of outward potassium current expression in human monocyte-derived macrophages: lack of correlation with secretion.

Authors:  D J Nelson; B Jow; F Jow
Journal:  J Membr Biol       Date:  1992-02       Impact factor: 1.843

Review 3.  The rise and rise of Staphylococcus aureus: laughing in the face of granulocytes.

Authors:  S Anwar; L R Prince; S J Foster; M K B Whyte; I Sabroe
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

4.  Bacteria induce release of platelet-activating factor (PAF) from polymorphonuclear neutrophil granulocytes: possible role for PAF in pathogenesis of experimentally induced bacterial pneumonia.

Authors:  A Makristathis; F Stauffer; S M Feistauer; A Georgopoulos
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

5.  Genomic analysis of variability in Delta-toxin levels between Staphylococcus aureus strains.

Authors:  Michelle Su; James T Lyles; Robert A Petit Iii; Jessica Peterson; Michelle Hargita; Huaqiao Tang; Claudia Solis-Lemus; Cassandra L Quave; Timothy D Read
Journal:  PeerJ       Date:  2020-03-24       Impact factor: 2.984

Review 6.  Microorganisms and exacerbation of chronic obstructive pulmonary diseases: pathophysiological mechanisms.

Authors:  P Clementsen; K S Kristensen; S Norn
Journal:  Allergy       Date:  1992-06       Impact factor: 13.146

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.